Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid

Gravani, Agoritsa; Christou, Panagiota; Tigas, Stelios; Bassukas, Ioannis D

Gravani, Agoritsa; Christou, Panagiota; Tigas, Stelios; Bassukas, Ioannis D.

Gravani, Agoritsa; University Hospital of Ioannina. Department of Dermatology. GR
Christou, Panagiota; University Hospital of Ioannina. Department of Endocrinology and Diabetes Centre. Ioannina. GR
Tigas, Stelios; University Hospital of Ioannina. Department of Endocrinology and Diabetes Centre. Ioannina. GR
Bassukas, Ioannis D; University Hospital of Ioannina. Department of Dermatology. Ioannina. GR

An. bras. dermatol ; 96(6): 782-784, Nov.-Dec. 2021. tab

Article in English | LILACS | ID: biblio-1355645

Subject(s)

Humans; Pemphigoid, Bullous/chemically induced; Pemphigoid, Bullous/drug therapy; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Case-Control Studies; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Pemphigoid, Bullous / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors Type of study: Observational study / Risk factors Limits: Humans Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2021 Type: Article Affiliation country: Greece Institution/Affiliation country: University Hospital of Ioannina/GR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google